Inventor · disambiguated record
Bing Shi
Also filed as: SHI BING · SHI BING Z · SHI BING ZHI
45 granted patents·12 pending applications·347 citations·filing 1995–2024
98Inventor score
Files withGILEAD SCIENCES INC34GILEAD PHARMASSET LLC9GILEAD CALISTOGA LLC3UNIV EMORY3AGOURON PHARMA2
Top patents by PatentIndex Score
57 records- 0197US11845739B2Solid forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2022·Granted Dec 19, 2023·6 cites·23 claims
- 0297US11266638B2Choline salt forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2020·Granted Mar 8, 2022·7 cites·23 claims
- 0396US11833143B2Choline salt forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2022·Granted Dec 5, 2023·3 cites·28 claims
- 0496US11655237B2Solid forms of a Cot inhibitor compoundGILEAD SCIENCES INC·Filed 2021·Granted May 23, 2023·6 cites·47 claims
- 0596US11117886B2Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2020·Granted Sep 14, 2021·15 cites·22 claims
- 0696US10849892B2Choline salt forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2018·Granted Dec 1, 2020·22 cites·22 claims
- 0795US11267799B2Solid forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2018·Granted Mar 8, 2022·8 cites·20 claims
- 0894US8865730B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2013·Granted Oct 21, 2014·25 cites·12 claims
- 0993US11613553B2Methods of preparing 1′-cyano nucleosidesGILEAD SCIENCES INC·Filed 2021·Granted Mar 28, 2023·19 cites·12 claims
- 1093US10696657B2Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2019·Granted Jun 30, 2020·22 cites·21 claims
- 1193US9469613B2(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGILEAD SCIENCES INC·Filed 2015·Granted Oct 18, 2016·15 cites·23 claims
- 1292US12492189B2Solid forms of an HIV capsid inhibitorGILEAD SCIENCES INC·Filed 2023·Granted Dec 9, 2025·1 cites·17 claims
- 1392US8969588B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2013·Granted Mar 3, 2015·17 cites·17 claims
- 1492US8754065B2Tenofovir alafenamide hemifumarateLIU DAZHAN·Filed 2012·Granted Jun 17, 2014·59 cites·31 claims
- 1589US9884873B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2017·Granted Feb 6, 2018·6 cites·20 claims
- 1689US9630972B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2015·Granted Apr 25, 2017·6 cites·10 claims
- 1788US9469643B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2014·Granted Oct 18, 2016·9 cites·6 claims
- 1887US8841340B2Solid forms of an antiviral compoundGILEAD SCIENCES INC·Filed 2013·Granted Sep 23, 2014·9 cites·26 claims
- 1987US7232910B2Methods of preparing indazole compoundsAGOURON PHARMA·Filed 2005·Granted Jun 19, 2007·27 cites·4 claims
- 2086US10604530B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2017·Granted Mar 31, 2020·2 cites·20 claims
- 2184USRE49445EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2020·Granted Mar 7, 2023·1 cites·62 claims
- 2284US11440928B2Crystalline forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2019·Granted Sep 13, 2022·1 cites·22 claims
- 2384US10730879B2Polymorphic forms of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-oneGILEAD CALISTOGA LLC·Filed 2016·Granted Aug 4, 2020·2 cites·4 claims
- 2484US2025100999A1Methods and intermediates for preparing therapeutic compoundsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 2583US9809559B2(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGILEAD SCIENCES INC·Filed 2016·Granted Nov 7, 2017·3 cites·16 claims
- 2683US9409891B2Solid forms of an antiviral compoundGILEAD SCIENCES INC·Filed 2014·Granted Aug 9, 2016·5 cites·24 claims
- 2783US9139570B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2015·Granted Sep 22, 2015·3 cites·5 claims
- 2883US6162417APyrrolo isoquinolinesUNIV EMORY·Filed 1998·Granted Dec 19, 2000·29 cites·35 claims
- 2983US2024245669A1Choline Salt Forms of an HIV Capsid InhibitorGILEAD SCIENCES INC·Filed 2023·Application pending·0 cites
- 3082US10287307B2Crystalline forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2018·Granted May 14, 2019·2 cites·22 claims
- 3182US2025215031A1Crystalline forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3281USRE48285EN-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideSIERRA ONCOLOGY INC·Filed 2018·Granted Oct 27, 2020·2 cites·26 claims
- 3381US9296769B2Tenofovir alafenamide hemifumarateGILEAD SCIENCES INC·Filed 2014·Granted Mar 29, 2016·5 cites·19 claims
- 3480USRE50497E(N-(cyanomethyl)-4-(2-(4-morpholinophenylamino)pyrimidin-4-yl)benzamideGLAXOSMITHKLINE LLC·Filed 2023·Granted Jul 22, 2025·0 cites·47 claims
- 3580US9682987B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2015·Granted Jun 20, 2017·2 cites·3 claims
- 3679US12202849B2Crystalline forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2022·Granted Jan 21, 2025·0 cites·22 claims
- 3779US2024409575A1Methods of preparing 1'-cyano nucleosidesGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 3874US10155781B2Co-crystals, salts and solid forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2017·Granted Dec 18, 2018·1 cites·6 claims
- 3974US9340568B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2014·Granted May 17, 2016·4 cites·10 claims
- 4072US9777028B2Co-crystals, salts and solid forms of tenofovir alafenamideGILEAD SCIENCES INC·Filed 2016·Granted Oct 3, 2017·1 cites·12 claims
- 4170US11203599B2Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2020·Granted Dec 21, 2021·0 cites·4 claims
- 4269US12486252B2Solid forms of a Cot inhibitor compoundGILEAD SCIENCES INC·Filed 2023·Granted Dec 2, 2025·0 cites·36 claims
- 4369US2025011352A1Solid formsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 4468US2025101057A1Solid formsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 4564US2025136603A1Methods and intermediates for preparing antiviral prodrugsGILEAD SCIENCES INC·Filed 2024·Application pending·0 cites
- 4657US2017327488A1Solid forms of an antiviral compoundGILEAD PHARMASSET LLC·Filed 2017·Application pending·0 cites
- 4756US10407438B2Crystalline forms of darunavirGILEAD SCIENCES INC·Filed 2017·Granted Sep 10, 2019·0 cites·13 claims
- 4856US2024317746A1Crystalline forms of an azetidine parp1 inhibitorXINTHERA INC·Filed 2024·Application pending·0 cites
- 4951US10851125B2Crystalline forms of ethyl ((S)-((((2R,5R)-5-(6-amino-9H-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl(-L-alaninateGILEAD SCIENCES INC·Filed 2018·Granted Dec 1, 2020·0 cites·14 claims
- 5051US10370381B2Inhibitors of bruton'S tyrosine kinaseGILEAD SCIENCES INC·Filed 2018·Granted Aug 6, 2019·0 cites·32 claims
Showing the top 50 of 57 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Bing Shi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →